A different QSP model for anti-CD19 chimeric antigen receptor T cells (CAR T) in a patient with chronic lymphocytic leukemia (CLL) was developed by Hardiansyah et al. [114]. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.